Rheumatology News and Research

RSS

Rheumatology is a sub-specialty in internal medicine and pediatrics, devoted to the diagnosis and therapy of rheumatic diseases. Rheumatologists mainly deal with clinical problems involving joints, soft tissues and allied conditions of connective tissues.

Rheumatoid arthritis costs more to business and industry than almost any other disease

Speaking at a rheumatology congress in Vienna today (Thursday 9 June), USA experts estimated that RA costs employers over $4,000 more per person, per year.

9 Jun 2005

Rituximab, used to treat rheumatoid arthritis (RA) is safe and effective

Professor Paul Emery from the University of Leeds in the UK led the DANCER study (Double blind placebo controlled dose ranging study), designed to confirm the efficacy of rituximab for the treatment of patients with active RA who have failed to improve on one or more disease modifying anti-rheumatic drugs (DMARDs).

9 Jun 2005

Rituximab provides new hope for people with lupus

Rheumatologists at the Annual European Congress of Rheumatology in Vienna, Austria heard today (Thursday 9 June) that rituximab is the first drug in a quarter of a century that is making a real impact, and an alternative to previous standard treatments of high-dose steroids, and chemotherapy.

9 Jun 2005

Arthritis patients still suffer as drugs guidelines are ignored

Access to drugs whose use was approved by the UK's National Institute for Health and Clinical Excellence (NICE) three years ago is still being denied to patients with severe rheumatoid arthritis.

7 Jun 2005

Better care for rheumatoid arthritis sufferers

Doctors and nurses from Europe and America have been learning about an innovative way, pioneered in Bristol, to help rheumatoid arthritis sufferers.

6 Jun 2005

Association between inflammation from knee injuries and a progressive loss of joint lubrication

Researchers have found an association between inflammation from knee injuries and a progressive loss of joint lubrication, which may predispose people to arthritis. They have also found a way to quantify how much lubrication is lost following injury.

3 Jun 2005

Common over-the-counter cough medication dextromethorphan may help people with fibromyalgia

About 10 million Americans, most of them women suffer from fibromyalgia, an incurable illness that causes stiffness, fatigue, muscle aches and sleep disturbances.

29 May 2005

Dextromethorphan temporarily reduces the intensity of fibromyalgia

Dextromethorphan, an over-the-counter medication that silences coughs, may help fibromyalgia patients quiet over-reacting nerves that amplify ordinary touches into agony.

20 May 2005

Research offers hope for treatment of age-related blindness

Rheumatoid arthritis patients treated with anti-inflammatory drugs are 10 times less likely to develop age-related macular degeneration (AMD), the most common form of blindness in people over 55, researchers at the University of British Columbia and University of Saskatchewan have found.

27 Apr 2005

Molecular switch may help fight off MRSA

The discovery of a 'molecular switch' could lead to new ways of treating infections such as MRSA, and inflammatory diseases like arthritis.

27 Apr 2005

Herbal remedies and arthritis drugs can be a potentially dangerous mix

Herbal remedies and arthritis drugs can be a potentially dangerous mix, but it's not only patients who are ill informed about the risks, healthcare professionals are too, suggests a survey, reported in the Annals of the Rheumatic Diseases.

19 Apr 2005

Drug that reduces the pain of fibromyalgia and improves sleep

A study of a drug that reduces the pain of fibromyalgia and improves sleep is published by a University of Kentucky physician in the peer-reviewed journal, Arthritis & Rheumatism.

12 Apr 2005

Study predicted cardiovascular risk of Cox-2 inhibitors

Amid the recent controversy and confusion over serious side effects from pain medications, a new UCLA and Veterans Affairs Greater Los Angeles Healthcare System study demonstrates that for arthritis sufferers at high risk for gastrointestinal problems who traditionally may have used a drug like Vioxx, the most cost-effective and safest treatment is actually a common painkiller combined with an acid-reducing drug.

11 Apr 2005

Experts call for improved access to treatment for psoriatic arthritis

MPs gathered at the House of Commons on Tuesday (April 5th) as experts and patient groups urged members of parliament to lobby for improved access to treatment for patients with psoriatic arthritis, a little known and poorly understood condition in which patients experience symptoms of both psoriasis and arthritis.

6 Apr 2005

Important that menopause not viewed as a disease

An independent panel convened last week by the National Institutes of Health found that many women move through the menopausal transition with few disabling symptoms, and that it is important that menopause not be viewed as a disease.

28 Mar 2005

Inflammation is a strong risk factor for cardiovascular disease among rheumatoid arthritis patients

Mayo Clinic epidemiologists have found that the systemic inflammation characterizing rheumatoid arthritis may be to blame for the increased risk of cardiovascular death in patients with the disease.

3 Mar 2005

Measuring hyaluronan in joints and fluid that lubricates cartilage might enable doctors to diagnose osteoarthritis more accurately

Measuring a biological chemical called hyaluronan found naturally in joints and the fluid that lubricates cartilage might enable doctors to diagnose osteoarthritis of the knee and hip earlier or more accurately, a new study concludes.

27 Feb 2005

People with rheumatoid arthritis have more silent, unrecognized heart attacks and sudden cardiac deaths

People with rheumatoid arthritis not only have a higher risk of coronary heart disease than those in the general population, but they have more silent, unrecognized heart attacks and sudden cardiac deaths, according to a Mayo Clinic study published in the February issue of Arthritis & Rheumatism.

3 Feb 2005

Promising new evidence for the optimal use of biologic therapies for rheumatoid arthritis

A major cause of pain and disability, rheumatoid arthritis (RA) is also potentially the most treatable form of chronic arthritis. Researchers, doctors, and patients agree that a group of drugs called disease-modifying antirheumatic drugs (DMARDs) can effectively reduce joint pain and stiffness.

7 Jan 2005

Red meat consumption is an independent risk factor in the development of inflammatory arthritis

A chronic inflammatory disease of the immune system, rheumatoid arthritis (RA) has been linked to a combination of genetic and environmental factors.

2 Dec 2004

Rheumatology News and Research

Further Reading

Rheumatoid arthritis costs more to business and industry than almost any other disease

Rituximab, used to treat rheumatoid arthritis (RA) is safe and effective

Rituximab provides new hope for people with lupus

Arthritis patients still suffer as drugs guidelines are ignored

Better care for rheumatoid arthritis sufferers

Association between inflammation from knee injuries and a progressive loss of joint lubrication

Common over-the-counter cough medication dextromethorphan may help people with fibromyalgia

Dextromethorphan temporarily reduces the intensity of fibromyalgia

Research offers hope for treatment of age-related blindness

Molecular switch may help fight off MRSA

Herbal remedies and arthritis drugs can be a potentially dangerous mix

Drug that reduces the pain of fibromyalgia and improves sleep

Study predicted cardiovascular risk of Cox-2 inhibitors

Experts call for improved access to treatment for psoriatic arthritis

Important that menopause not viewed as a disease

Inflammation is a strong risk factor for cardiovascular disease among rheumatoid arthritis patients

Measuring hyaluronan in joints and fluid that lubricates cartilage might enable doctors to diagnose osteoarthritis more accurately

People with rheumatoid arthritis have more silent, unrecognized heart attacks and sudden cardiac deaths

Promising new evidence for the optimal use of biologic therapies for rheumatoid arthritis

Red meat consumption is an independent risk factor in the development of inflammatory arthritis

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News